Welcome!
Thanks for your interest in our program! We have made the decision to early commit for the 2023-2024 academic year. We wish you continued success and hope you consider applying for future EM team opportunities at Inova!
How Long Has Inova's PGY-2 Emergency Medicine Pharmacy Residency Program Existed?
The PGY-2 Emergency Medicine Pharmacy Residency Program enrolled its first resident in July of 2014 and received ASHP accreditation in 2015. Our past graduates have gone on to practice as Emergency Medicine pharmacists at hospitals around the country, as well as here at Inova.
During What Hours Are Pharmacists Available in the Emergency Department at Inova Fairfax Medical Campus?
Through a combination of an Emergency Medicine Clinical Pharmacy Specialist, Emergency Medicine/Critical Care-trained Decentralized Pharmacists and our PGY-2 Emergency Medicine Pharmacy Resident, we provide coverage 7 days a week from 8 a.m. to midnight.
How Many Residents Do You Accept?
We have one residency position available.
Do You Conduct Interviews in the Personnel Placement Service (PPS) During the ASHP Midyear Clinical Meeting?
Can you describe the Clinical on Call (COC) program?
The COC program was developed to provide clinical decision support to our decentralized pharmacy team. Residents take call in 1-week blocks beginning on Friday afternoon and ending the following Friday. On average, residents receive one consult per day. Common consults include escalation of restricted medication approvals and decision support for off-label or non-standard medication therapies. This is not an "in house" call service.
What is a clinical controversy journal club?
Rather than a journal club assessing one piece of literature as is common in APPE rotations and PGY1 residencies, the clinical controversy journal club is an innovative format designed to help residents take their literature evaluation skills to the next level. Each journal club will center on a current controversy in Emergency Medicine. The resident is expected to provide background on the controversy followed by a deep dive into at least two relevant studies attempting to settle the controversy, and, finally, provide their recommendation for how the current body of evidence should be applied to patient management.